Eliminating parvovirus B19 from blood products
- 26 March 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 343 (8900), 798
- https://doi.org/10.1016/s0140-6736(94)91878-3
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentratesAmerican Journal of Hematology, 1992
- Persistent B19 Parvovirus Infection in Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1): A Treatable Cause of Anemia in AIDSAnnals of Internal Medicine, 1990